JP2013535436A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013535436A5 JP2013535436A5 JP2013519178A JP2013519178A JP2013535436A5 JP 2013535436 A5 JP2013535436 A5 JP 2013535436A5 JP 2013519178 A JP2013519178 A JP 2013519178A JP 2013519178 A JP2013519178 A JP 2013519178A JP 2013535436 A5 JP2013535436 A5 JP 2013535436A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- activation
- cannabinoid receptor
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 31
- 239000000243 solution Substances 0.000 claims 7
- 102000013674 S-100 Human genes 0.000 claims 6
- 108700021018 S100 Proteins 0.000 claims 6
- 239000012895 dilution Substances 0.000 claims 5
- 238000010790 dilution Methods 0.000 claims 5
- 230000001632 homeopathic effect Effects 0.000 claims 5
- 101000710899 Homo sapiens Cannabinoid receptor 1 Proteins 0.000 claims 4
- 241000124008 Mammalia Species 0.000 claims 4
- 102000056964 human CNR1 Human genes 0.000 claims 4
- 102000018208 Cannabinoid Receptor Human genes 0.000 claims 3
- 108050007331 Cannabinoid receptor Proteins 0.000 claims 3
- 238000005259 measurement Methods 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 238000012360 testing method Methods 0.000 claims 3
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims 2
- 101710187010 Cannabinoid receptor 1 Proteins 0.000 claims 2
- 102100033868 Cannabinoid receptor 1 Human genes 0.000 claims 2
- 230000008901 benefit Effects 0.000 claims 2
- 239000002552 dosage form Substances 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 229960002715 nicotine Drugs 0.000 claims 2
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 201000006152 substance dependence Diseases 0.000 claims 2
- 208000011117 substance-related disease Diseases 0.000 claims 2
- 206010057852 Nicotine dependence Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 208000025569 Tobacco Use disease Diseases 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 230000008859 change Effects 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 238000007865 diluting Methods 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 235000012631 food intake Nutrition 0.000 claims 1
- 230000006872 improvement Effects 0.000 claims 1
- 208000030159 metabolic disease Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 235000018770 reduced food intake Nutrition 0.000 claims 1
- 230000009467 reduction Effects 0.000 claims 1
- 230000005586 smoking cessation Effects 0.000 claims 1
- 230000000391 smoking effect Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000004584 weight gain Effects 0.000 claims 1
- 235000019786 weight gain Nutrition 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2010129289/15A RU2552221C2 (ru) | 2010-07-15 | 2010-07-15 | Способ лечения ожирения и сопутствующих метаболических расстройств и лекарственное средство для лечения ожирения и сопутствующих метаболических расстройств |
| RU2010129289 | 2010-07-15 | ||
| RU2010130350/15A RU2533224C2 (ru) | 2010-07-21 | 2010-07-21 | Способ лечения зависимости от психоактивных веществ, алкоголизма и табакокурения и лекарственное средство для лечения зависимости от психоактивных веществ, алкоголизма и табакокурения |
| RU2010130350 | 2010-07-21 | ||
| RU2011122407 | 2011-06-02 | ||
| RU2011122407A RU2610438C2 (ru) | 2011-06-02 | 2011-06-02 | Способ лечения патологического синдрома и лекарственное средство центрального и периферического действия для лечения патологического синдрома |
| PCT/IB2011/002404 WO2012007847A2 (en) | 2010-07-15 | 2011-07-15 | Pharmaceutical compositions and methods of treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013535436A JP2013535436A (ja) | 2013-09-12 |
| JP2013535436A5 true JP2013535436A5 (enExample) | 2014-04-24 |
Family
ID=44899164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013519178A Pending JP2013535436A (ja) | 2010-07-15 | 2011-07-15 | 医薬組成物及び治療方法 |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US8865163B2 (enExample) |
| EP (1) | EP2593477A2 (enExample) |
| JP (1) | JP2013535436A (enExample) |
| KR (1) | KR20140012009A (enExample) |
| CN (1) | CN103124742A (enExample) |
| AR (1) | AR082246A1 (enExample) |
| AU (1) | AU2011278040B2 (enExample) |
| BR (1) | BR112013000841A2 (enExample) |
| CA (1) | CA2805091A1 (enExample) |
| CL (1) | CL2013000098A1 (enExample) |
| CZ (1) | CZ2013104A3 (enExample) |
| DE (1) | DE112011102349T5 (enExample) |
| DK (1) | DK201370078A (enExample) |
| EA (1) | EA029400B1 (enExample) |
| EE (1) | EE05760B1 (enExample) |
| ES (1) | ES2542042R1 (enExample) |
| FI (1) | FI20135146L (enExample) |
| FR (1) | FR2962653A1 (enExample) |
| GB (1) | GB2496076B (enExample) |
| IT (1) | ITTO20110641A1 (enExample) |
| LT (1) | LT5987B (enExample) |
| MX (1) | MX361778B (enExample) |
| MY (1) | MY158183A (enExample) |
| NO (1) | NO20130219A1 (enExample) |
| NZ (1) | NZ606768A (enExample) |
| PE (1) | PE20131338A1 (enExample) |
| PH (1) | PH12013500109A1 (enExample) |
| SE (1) | SE1350179A1 (enExample) |
| SG (1) | SG187037A1 (enExample) |
| WO (1) | WO2012007847A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2181297C2 (ru) | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| RU2309732C1 (ru) * | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата |
| FR2962652A1 (fr) | 2010-07-15 | 2012-01-20 | Oleg Iliich Epshtein | Composition pharmaceutique d'association et son utilisation dans des procedes pour traiter les maladies ou affections associees a des maladies neurodegeneratives |
| MX2013000543A (es) | 2010-07-15 | 2013-10-28 | Oleg Iliich Epshtein | Un metodo para aumentar el efecto de una forma activa potenciada de un anticuerpo. |
| FR2962655A1 (fr) * | 2010-07-15 | 2012-01-20 | Oleg Iliich Epshtein | Composition pharmaceutique d'association et ses utilisations dans les procedes de traitement des troubles du systeme genito-urinaire |
| PH12013500144A1 (en) | 2010-07-21 | 2018-03-21 | Oleg Iliich Epshtein | A method of treating attention deficit hyperactivity disorder |
| CN103118707A (zh) * | 2010-07-21 | 2013-05-22 | 奥列格·伊里奇·爱泼斯坦 | 复合药物组合物及对糖尿病和代谢紊乱进行治疗的方法 |
| FR2962909A1 (fr) * | 2010-07-21 | 2012-01-27 | Oleg Iliich Epshtein | Composition pharmaceutique d'association et son utilisation dans des procedes pour traiter les maladies ou affections associees avec une maladie ou affection respiratoire |
| US20130058981A1 (en) * | 2010-07-21 | 2013-03-07 | Oleg Iliich Epshtein | Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia |
| CZ2013159A3 (cs) * | 2010-08-06 | 2013-06-12 | Iliich Epshtein@Oleg | Kombinovaná farmaceutická kompozice a zpusoby lécby a prevence infekcních chorob |
| RU2013111962A (ru) * | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
| RU2013111961A (ru) * | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
| JP6598844B2 (ja) * | 2014-03-27 | 2019-10-30 | バード・ロック・バイオ・インコーポレイテッド | ヒトカンナビノイド１（ｃｂ１）受容体に結合する抗体 |
| CN104524568B (zh) * | 2015-01-08 | 2018-04-20 | 中国人民解放军第二军医大学 | 一种治疗肥胖症的药物组合物及其应用 |
| JP2019502651A (ja) * | 2015-09-30 | 2019-01-31 | バード・ロック・バイオ・インコーポレイテッドＢｉｒｄ Ｒｏｃｋ Ｂｉｏ， Ｉｎｃ． | ヒトカンナビノイド１（ｃｂ１）受容体に結合する抗体 |
| CN114375200A (zh) * | 2019-08-29 | 2022-04-19 | 奥列格·伊利奇·爱泼斯坦 | 治疗传染病的药物和方法 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4311897A (en) | 1979-08-28 | 1982-01-19 | Union Carbide Corporation | Plasma arc torch and nozzle assembly |
| AU723812B2 (en) | 1996-02-12 | 2000-09-07 | Oleg Iliich Epshtein | Medicinal preparation and a method of medicinal action on human organism |
| US5849528A (en) | 1997-08-21 | 1998-12-15 | Incyte Pharmaceuticals, Inc.. | Polynucleotides encoding a human S100 protein |
| RU2156621C1 (ru) | 1999-03-04 | 2000-09-27 | Эпштейн Олег Ильич | Нейротропное лекарственное средство |
| RU2181297C2 (ru) | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| RU2201255C1 (ru) | 2001-12-26 | 2003-03-27 | Эпштейн Олег Ильич | Лекарственное средство и способ регуляции сосудистого тонуса |
| RU2209084C1 (ru) * | 2001-12-26 | 2003-07-27 | Эпштейн Олег Ильич | Лекарственное средство и способ лечения депрессивных расстройств |
| UA76641C2 (uk) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози |
| UA76640C2 (uk) * | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Спосіб корекції патологічних імунних реакцій та гомеопатичний лікарський засіб |
| UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
| UA76639C2 (uk) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій |
| GB2414670B (en) | 2003-03-14 | 2008-03-19 | Nutrition Res Inc | Homeopathic formulations useful for treating pain and/or inflammation |
| US20050100513A1 (en) * | 2003-11-10 | 2005-05-12 | Watkins Mary B. | Homeopathic method and system for treating nicotine addiction |
| EP1574211A1 (en) * | 2004-03-09 | 2005-09-14 | Inserm | Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases |
| RU2309732C1 (ru) * | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата |
| CA2654408C (en) * | 2006-06-06 | 2018-05-08 | Oleg Iliich Epshtein | Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance |
| RU2437678C2 (ru) | 2006-06-06 | 2011-12-27 | Олег Ильич Эпштейн | Лекарственное средство для перорального лечения ожирения и способ получения твердой лекарственной формы для пероральной терапии ожирения |
| RU2438707C2 (ru) * | 2006-06-06 | 2012-01-10 | Олег Ильич Эпштейн | Лекарственное средство для перорального лечения сахарного диабета и других заболеваний, сопровождающихся нарушением толерантности к глюкозе, и способ получения твердой лекарственной формы для пероральной терапии сахарного диабета и других заболеваний, сопровождающихся нарушением толерантности к глюкозе |
| AR063497A1 (es) * | 2006-10-23 | 2009-01-28 | Lilly Co Eli | Compuesto de pirrodinil -2-ona, intermediario para la sintesis del mismo, composicion farmaceutica que lo comprende y su uso para preparar un medicamento |
| EP1985295A1 (en) * | 2007-04-04 | 2008-10-29 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders |
| JP2010132631A (ja) * | 2008-11-04 | 2010-06-17 | Bizen Chemical Co Ltd | カンナビノイド受容体のインバースアゴニストおよびアンタゴニスト活性を有する組成物 |
| FR2962652A1 (fr) | 2010-07-15 | 2012-01-20 | Oleg Iliich Epshtein | Composition pharmaceutique d'association et son utilisation dans des procedes pour traiter les maladies ou affections associees a des maladies neurodegeneratives |
| MY157564A (en) | 2010-07-15 | 2016-06-30 | Epshtein Oleg Lliich | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract |
| PH12013500144A1 (en) | 2010-07-21 | 2018-03-21 | Oleg Iliich Epshtein | A method of treating attention deficit hyperactivity disorder |
| US20130058981A1 (en) | 2010-07-21 | 2013-03-07 | Oleg Iliich Epshtein | Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystonia |
| WO2012010978A2 (en) | 2010-07-21 | 2012-01-26 | Oleg Iliich Epshtein | A method of treating alzheimer's disease |
| WO2012014078A2 (en) | 2010-07-21 | 2012-02-02 | Olge Iliich Epshtein | Method of treatment of organic diseases of nervous system, psychoorganic syndrome and encephalopathy |
| CN103118707A (zh) | 2010-07-21 | 2013-05-22 | 奥列格·伊里奇·爱泼斯坦 | 复合药物组合物及对糖尿病和代谢紊乱进行治疗的方法 |
-
2011
- 2011-07-15 EA EA201300133A patent/EA029400B1/ru not_active IP Right Cessation
- 2011-07-15 EP EP11788222.5A patent/EP2593477A2/en not_active Ceased
- 2011-07-15 DE DE112011102349T patent/DE112011102349T5/de not_active Ceased
- 2011-07-15 KR KR1020137003750A patent/KR20140012009A/ko not_active Ceased
- 2011-07-15 AU AU2011278040A patent/AU2011278040B2/en not_active Ceased
- 2011-07-15 CA CA2805091A patent/CA2805091A1/en not_active Abandoned
- 2011-07-15 WO PCT/IB2011/002404 patent/WO2012007847A2/en not_active Ceased
- 2011-07-15 MY MYPI2013000110A patent/MY158183A/en unknown
- 2011-07-15 ES ES201390003A patent/ES2542042R1/es active Pending
- 2011-07-15 US US13/135,893 patent/US8865163B2/en not_active Expired - Fee Related
- 2011-07-15 CN CN2011800442270A patent/CN103124742A/zh active Pending
- 2011-07-15 NZ NZ606768A patent/NZ606768A/en not_active IP Right Cessation
- 2011-07-15 SE SE1350179A patent/SE1350179A1/sv unknown
- 2011-07-15 JP JP2013519178A patent/JP2013535436A/ja active Pending
- 2011-07-15 FI FI20135146A patent/FI20135146L/fi not_active IP Right Cessation
- 2011-07-15 GB GB1302653.9A patent/GB2496076B/en not_active Expired - Fee Related
- 2011-07-15 MX MX2013000545A patent/MX361778B/es active IP Right Grant
- 2011-07-15 FR FR1156473A patent/FR2962653A1/fr not_active Withdrawn
- 2011-07-15 IT IT000641A patent/ITTO20110641A1/it unknown
- 2011-07-15 EE EEP201300005A patent/EE05760B1/et not_active IP Right Cessation
- 2011-07-15 BR BR112013000841A patent/BR112013000841A2/pt not_active IP Right Cessation
- 2011-07-15 PH PH1/2013/500109A patent/PH12013500109A1/en unknown
- 2011-07-15 SG SG2013002316A patent/SG187037A1/en unknown
- 2011-07-15 PE PE2013000073A patent/PE20131338A1/es not_active Application Discontinuation
- 2011-07-15 CZ CZ20130104A patent/CZ2013104A3/cs unknown
- 2011-07-18 AR ARP110102576A patent/AR082246A1/es unknown
-
2013
- 2013-01-10 CL CL2013000098A patent/CL2013000098A1/es unknown
- 2013-02-08 NO NO20130219A patent/NO20130219A1/no not_active Application Discontinuation
- 2013-02-14 DK DKPA201370078A patent/DK201370078A/da not_active Application Discontinuation
- 2013-02-14 LT LT2013015A patent/LT5987B/lt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013535436A5 (enExample) | ||
| JP7257374B2 (ja) | Ｔ制御性細胞の増殖または枯渇方法 | |
| Qiu et al. | Functional proteins of mesenchymal stem cell-derived extracellular vesicles | |
| JP2013535445A5 (enExample) | ||
| Pietra et al. | Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile | |
| JP2013537532A5 (enExample) | ||
| JP2015530404A5 (enExample) | ||
| JP2009286793A5 (enExample) | ||
| JP2013541335A5 (enExample) | ||
| JP2013532181A5 (enExample) | ||
| RU2539774C3 (ru) | Человеческие антитела с высокой аффинностью к рецепторам il-4 человека | |
| WO2013120012A3 (en) | Cdim binding proteins and uses thereof | |
| HRP20150799T1 (hr) | Sastavi i postupci za protutijela protiv komplementnog proteina c5 | |
| JP2013533269A5 (enExample) | ||
| JP2010532761A5 (enExample) | ||
| ES3001197T3 (es) | Agente de unión anti-adrenomedulina (ADM) para su uso en la terapia o prevención de síntomas de enfermedad | |
| JP2013538195A5 (enExample) | ||
| JP2012522788A5 (enExample) | ||
| CN110407938A (zh) | 抗tim-3单克隆抗体、表达载体及其应用 | |
| Pan et al. | Poliovirus receptor–based chimeric antigen receptor T cells combined with NK-92 cells exert potent activity against glioblastoma | |
| Padayachee et al. | The nose as a route for therapy. Part 2 immunotherapy | |
| CN109897107B (zh) | 纳米抗体及其制备方法 | |
| Li et al. | A neutralizing-protective supersite of human monoclonal antibodies for yellow fever virus | |
| CN112390884B (zh) | Semaphorin7A单克隆抗体及其在制备用于治疗炎症疾病药物方面的应用 | |
| JP2015512923A5 (enExample) |